These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3089950)

  • 1. Serum levels and pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients during chronic dosage.
    Thornhill DP
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):257-61. PubMed ID: 3089950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients after acute dosage.
    Thornhill DP
    Eur J Clin Pharmacol; 1978 Dec; 14(4):267-71. PubMed ID: 365541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel slow-release formulation of lithium carbonate (Carbolithium Once-A-Day) vs. standard Carbolithium: a comparative pharmacokinetic study.
    Castrogiovanni P
    Clin Ter; 2002; 153(2):107-15. PubMed ID: 12078335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.
    Arancibia A; Corvalan F; Mella F; Concha L
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of lithium levels for dose and blood sampling times.
    Swartz CM
    J Clin Psychiatry; 1987 Feb; 48(2):60-4. PubMed ID: 3804990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of standard (lithicarb) and sustained-release (Priadel) lithium carbonate preparations in patients.
    Johnson GF; Hunt GE; Lewis J; St George B
    Aust N Z J Psychiatry; 1982 Mar; 16(1):64-8. PubMed ID: 6810866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of standard and slow-release oral lithium carbonate products.
    Wallis J; Miller R; McFadyen ML; Carlile JB
    S Afr Med J; 1989 Dec; 76(11):618-20. PubMed ID: 2512655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of lithium carbonate and lithium citrate: a comparison of two controlled-release preparations.
    Tyrer SP; Peat MA; Minty PS; Luchini A; Glud V; Amdisen A
    Pharmatherapeutica; 1982; 3(4):243-6. PubMed ID: 6815664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of long-acting lithium carbonate--micalite--in the treatment of affective psychoses].
    Khvilivitskiĭ TIa; Mikhalenko IN; Zlatikina GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(4):583-7. PubMed ID: 868433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single dose pharmacokinetics of a controlled release lithium preparation "Liskonum" in African patients suffering from manic depressive psychosis.
    Mengech HN; Ojwang PJ
    East Afr Med J; 1984 Apr; 61(4):321-5. PubMed ID: 6489236
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevated serum bromide in patients taking lithium carbonate.
    Handorf CR; Coleman JH; Rawls WN
    J Clin Psychiatry; 1985 Jan; 46(1):9-10. PubMed ID: 3917430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparison of EEG changes with reaction time and serum lithium levels during treatment of manic patients with lithium carbonate].
    Shen JH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Apr; 21(2):83-6, 126-7. PubMed ID: 3145174
    [No Abstract]   [Full Text] [Related]  

  • 14. Three cases of severe mania successfully treated with high-dosage lithium-carbonate.
    Thau K; Meszaros K; Simhandl C
    Pharmacopsychiatry; 1991 May; 24(3):85-8. PubMed ID: 1909797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Slow-release lithium carbonate versus standard preparation in bipolar affective disorders (author's transl)].
    Bohacek N; Mihovilović M
    Lijec Vjesn; 1980 Oct; 102(10):575-9. PubMed ID: 6790888
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of individual pharmacokinetic parameters in establishing a regimen for lithium administration].
    Pop RD; Leucuţa SE; Domuţa M; Fodoreanu L; Barna D; Kovacs A; Gabor S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1984; 29(3):223-7. PubMed ID: 6239352
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of haloperidol on serum levels of lithium in adult manic patients.
    Schaffer CB; Batra K; Garvey MJ; Mungas DM; Schaffer LC
    Biol Psychiatry; 1984 Oct; 19(10):1495-9. PubMed ID: 6440599
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspect of the pharmacokinetics of slow-release lithium carbonate.
    Hart GA
    S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Compliance with and tolerance of sustained-release lithium carbonate].
    Lavantes B; Senimon F; Bayle FJ
    Encephale; 1999; 25(2):152-7. PubMed ID: 10370888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review?
    Severus WE; Kleindienst N; Seemüller F; Frangou S; Möller HJ; Greil W
    Bipolar Disord; 2008 Mar; 10(2):231-7. PubMed ID: 18271901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.